THC Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
THC Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q4 2023.
  • THC Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending January 31, 2024 was -$572K, a 134% decline year-over-year.
  • THC Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending January 31, 2024 was -$573K, a 21.3% increase year-over-year.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$387K, a 74.5% increase from 2022.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$1.52M, a 19.4% increase from 2021.
  • THC Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$1.89M, a 319% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$573K -$572K -$2.26M -134% Nov 1, 2023 Jan 31, 2024 10-Q 2024-09-05
Q3 2023 $1.68M -$62.5K +$2.07M +97.1% Aug 1, 2023 Oct 31, 2023 10-Q 2024-09-05
Q2 2023 -$387K -$32.9K -$385K -109% May 1, 2023 Jul 31, 2023 10-K 2024-02-26
Q1 2023 -$1.85K $94.4K +$727K Feb 1, 2023 Apr 30, 2023 10-Q 2024-01-09
Q4 2022 -$728K $1.69M +$2.44M Nov 1, 2022 Jan 31, 2023 10-Q 2024-09-05
Q3 2022 -$3.17M -$2.13M -$1.65M -339% Aug 1, 2022 Oct 31, 2022 10-Q 2024-09-05
Q2 2022 -$1.52M $352K +$1.44M May 1, 2022 Jul 31, 2022 10-K 2024-02-26
Q1 2022 -$2.96M -$632K -$281K -80.2% Feb 1, 2022 Apr 30, 2022 10-Q 2024-01-09
Q4 2021 -$2.67M -$752K -$393K -109% Nov 1, 2021 Jan 31, 2022 10-Q 2024-01-09
Q3 2021 -$2.28M -$486K -$396K -440% Aug 1, 2021 Oct 31, 2021 10-Q 2024-01-09
Q2 2021 -$1.89M -$1.08M May 1, 2021 Jul 31, 2021 10-K 2022-11-25
Q1 2021 -$351K +$909K +72.2% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-16
Q4 2020 -$360K +$507K +58.5% Nov 1, 2020 Jan 31, 2021 10-Q 2022-06-16
Q3 2020 -$90.1K +$55.4K +38.1% Aug 1, 2020 Oct 31, 2020 10-Q 2022-05-16
Q1 2020 $534K -$1.26M +$20.9M +94.3% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-22
Q4 2019 -$20.3M -$867K +$2.68M +75.5% Nov 1, 2019 Jan 31, 2020 10-Q 2021-06-22
Q3 2019 -$23M -$145K +$293K +66.9% Aug 1, 2019 Oct 31, 2019 10-Q 2021-06-22
Q2 2019 -$23.3M $2.81M +$8.42M May 1, 2019 Jul 31, 2019 10-K 2020-11-04
Q1 2019 -$31.7M -$22.1M -$21.9M -8968% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-22
Q4 2018 -$9.84M -$3.54M -$3.4M -2373% Nov 1, 2018 Jan 31, 2019 10-Q 2020-06-22
Q3 2018 -$6.44M -$439K -$305K -227% Aug 1, 2018 Oct 31, 2018 10-Q 2020-06-22
Q2 2018 -$6.14M -$5.62M May 1, 2018 Jul 31, 2018 10-K/A 2019-11-18
Q1 2018 -$244K Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-14
Q4 2017 -$143K Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-15
Q3 2017 -$134K Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-19
Q1 2013 -$318K -$20.3K -$9.51K -88.1% Feb 1, 2013 Apr 30, 2013 10-Q 2013-06-11
Q4 2012 -$309K -$51.2K -$48.8K -2033% Nov 1, 2012 Jan 31, 2013 10-Q 2013-03-21
Q3 2012 -$260K -$20.1K -$18.4K -1083% Aug 1, 2012 Oct 31, 2012 10-Q 2012-12-14
Q2 2012 -$242K -$227K -$213K -1573% May 1, 2012 Jul 31, 2012 10-K 2012-11-13
Q1 2012 -$28.4K -$10.8K -$9.4K -675% Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-11
Q4 2011 -$19K -$2.4K +$6.41K +72.8% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-21
Q3 2011 -$25.5K -$1.7K -$678 -66.3% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 -$24.8K -$13.5K May 1, 2011 Jul 31, 2011 10-K 2012-11-13
Q1 2011 -$1.39K Feb 1, 2011 Apr 30, 2011 10-Q 2012-06-14
Q4 2010 -$8.81K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-21
Q3 2010 -$1.02K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.